Riskpilot← Back to searchSign inGet full accessANATOMIX AS
ASActiveOrg 920220096Torggata 10, 0181 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20181 employees
Revenue 2024
NOK 3,7M
-13% vs 2023
EBITDA margin
-29.0%
-1798% vs 2023
Equity ratio
0.7%
Financial strength
Net profit 2024
NOK -1,1M
-623% vs 2023
| Revenue | NOK 3,7M | -13% |
| EBITDA | NOK -1,1M | -1798% |
| Net profit | NOK -1,1M | -623% |
| Total assets | NOK 1,8M | -51% |
| Equity | NOK 13K | -99% |
| Employees | 1 | — |
Legal name
ANATOMIX AS
Org number
920220096
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10. januar 2018
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Salg av helserelaterte produkter og andre produkter og tjenester som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet. Kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Torggata 10, 0181 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 3 422 | 4 362 | 3 671 | 3 830 | 3 326 | 4 248 | 3 702 |
| Staff expenses | −675 | −676 | −668 | −460 | −600 | −809 | −1 002 |
| EBITDA | −88 | 56 | 223 | 559 | −224 | 63 | −1 072 |
| Depreciation & amort. | −114 | −47 | −45 | −1 | −19 | −25 | −24 |
| EBIT | −202 | 9 | 178 | 559 | −244 | 38 | −1 097 |
| Net financials | 180 | −17 | −26 | 512 | 70 | 168 | 17 |
| Profit before tax | −21 | −8 | 152 | 1 071 | −174 | 206 | −1 080 |
| Tax | −43 | 4 | 28 | 131 | 37 | −0 | −0 |
| Net profit | 22 | −13 | 124 | 940 | −211 | 206 | −1 080 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 1 991 | 2 094 | 2 190 | 2 705 | 2 487 | 3 724 | 1 807 |
| Equity | 47 | 34 | 157 | 1 097 | 886 | 1 093 | 13 |
| Long-term debt | 0 | 48 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 944 | 2 012 | 2 032 | 1 608 | 1 601 | 2 631 | 1 795 |
| Total debt | 1 944 | 2 060 | 2 032 | 1 608 | 1 601 | 2 631 | 1 795 |
EBITDA margin
-29.0%
This company
15.8%
Market median
-284% vs market
20182024
Equity ratio
0.7%
This company
38.2%
Market median
-98% vs market
20182024
Return on equity
-8533.2%
This company
18.4%
Market median
-46476% vs market
20182024
Net profit margin
-29.2%
This company
8.1%
Market median
-460% vs market
20182024
Asset turnover
2.05×
This company
1.12×
Market median
+83% vs market
20182024
Debt / equity
141.78×
This company
0.62×
Market median
-22768% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GR Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Anatomix Holding As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Anatomix Holding As
ANATOMIX AS Board members of ANATOMIX AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Guy Robert Giltun | Chief Executive Officer | 0 companies |
| Kristine Strømsæther Giltun | Board of Directors | 0 companies |